Related Experiment Video
Updated: Jan 1, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway
Henna Hakimee1, Pilaiwanwadee Hutamekalin2, Supita Tanasawet3
1Department of Pharmacology, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Background:
Metformin, an antidiabetic drug, has been previously reported to have anti-cancer activities. However, its role in the control of cancer cell migration remains elusive.
Methods:
To examine the possible effect of metformin on migration of cervical cancer cells. The related mechanisms were further determined by immunocytochemistry and Western's blotting assay.
Results:
The results showed that metformin treatment substantially inhibited the migration ability of cervical cancer cells. Consistently, the filopodia and lamellipodia formation were depleted after exposure to metformin. The suppression of migration mediated through the regulatory proteins such as focal adhesion kinase (FAK), ATP-dependent tyrosine kinase (Akt), Rac1 and RhoA after metformin treatment.
Conclusion:
Metformin displays antimigration effects in cervical cancer cells by inhibiting filopodia and lamellipodia formation through the suppression of FAK, Akt and its downstream Rac1 and RhoA protein. We propose that metformin could be a novel potential candidate as an antimetastatic cancer drug in the cervical cancer management.
Insights
Metformin significantly inhibits cervical cancer cell migration by reducing cell structures like filopodia and lamellipodia. This antimetastatic effect is mediated by suppressing key proteins involved in cell movement.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Metformin, an established antidiabetic medication, exhibits potential anti-cancer properties.
- The specific impact of metformin on cancer cell migration, particularly in cervical cancer, requires further elucidation.
Purpose of the Study:
- To investigate the effect of metformin on the migration of cervical cancer cells.
- To explore the underlying molecular mechanisms responsible for metformin's influence on cell migration.
Main Methods:
- Cervical cancer cell lines were treated with metformin.
- Immunocytochemistry and Western blotting assays were employed to analyze protein expression and cellular structures.
Main Results:
- Metformin treatment markedly reduced the migratory capacity of cervical cancer cells.
- Filopodia and lamellipodia formation were significantly diminished post-metformin exposure.
- Metformin suppressed key regulatory proteins including focal adhesion kinase (FAK), Akt, Rac1, and RhoA.
Conclusions:
- Metformin demonstrates antimigratory effects in cervical cancer by inhibiting filopodia and lamellipodia formation.
- This inhibition occurs through the downregulation of FAK, Akt, Rac1, and RhoA signaling pathways.
- Metformin presents a potential therapeutic candidate for managing cervical cancer metastasis.
Related Concept Videos
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades

